Literature DB >> 32425056

Reply to Dawes et al.

Abdullah Al Maruf1,2, Mikayla Fan3, Paul D Arnold1,2,4, Daniel J Müller5,6, Katherine Aitchison7,8, Chad A Bousman1,2,4,9,10.   

Abstract

Keywords:  implementation; pharmacogenetics; psychiatry

Mesh：

Year:  2020        PMID： 32425056      PMCID： PMC7492884          DOI： 10.1177/0706743720925736

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN： 0706-7437            Impact factor:   4.356


× No keyword cloud information.
  4 in total

Review 1.  Pharmacogenetic Testing Options Relevant to Psychiatry in Canada: Options de tests pharmacogénétiques pertinents en psychiatrie au Canada.

Authors:  Abdullah Al Maruf; Mikayla Fan; Paul D Arnold; Daniel J Müller; Katherine J Aitchison; Chad A Bousman
Journal:  Can J Psychiatry       Date:  2020-02-17       Impact factor: 4.356

2.  Re: Pharmacogenetic Testing Options Relevant to Psychiatry in Canada.

Authors:  Martin Dawes; Hagit Katzov-Eckert; Andrea Paterson; Diana Dawes
Journal:  Can J Psychiatry       Date:  2020-05-13       Impact factor: 4.356

3.  Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials.

Authors:  Chad A Bousman; Katarina Arandjelovic; Serafino G Mancuso; Harris A Eyre; Boadie W Dunlop
Journal:  Pharmacogenomics       Date:  2018-12-06       Impact factor: 2.533

4.  "Black box" pharmacogenetic decision-support tools in psychiatry.

Authors:  Chad A Bousman; Harris A Eyre
Journal:  Braz J Psychiatry       Date:  2020-01-24       Impact factor: 2.697
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.